drugset / Trial / NCT06114641
Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study is evaluating safety and effectiveness of Ovine Enoxaparin Sodium in Non-ST-Segment Elevation Acute Coronary Syndrome (NSTEACS) Patients
Timeline
- Start
- 2023-06-01
- Primary completion
- 2024-02-05
- Completion
- 2024-08-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Enoxaparin sodium | Other / unclassified | 1 mg/kg | Intravenous |
Indications
No indication recorded.